• Strategy
  • Innovation
  • Expertise

Acquisition of Vermont-based Captive

The Board of Randall & Quilter Investment Holdings Ltd. (AIM-RQIH) (“R&Q”), the leading non-life global specialty insurance company focusing on the Program Management and Legacy Insurance, is pleased to announce the acquisition of a captive insurer domiciled in Vermont. The …

26 June, 2020

Acquisition of NationsBuilders Insurance Company

Randall & Quilter Investment Holdings Ltd. (‘R&Q’ or ‘the Group’) is pleased to announce that its wholly owned Vermont subsidiary ICDC, Ltd. has entered into a stock purchase agreement to acquire NationsBuilders Insurance Company (“NBIC”), a Washington D.C. domiciled captive …

5 June, 2020

Loss Portfolio Transfer with Houston International Insurance Group

Randall & Quilter Investment Holdings Ltd. (‘R&Q’ or ‘the Group’) is pleased to announce, following approval from the Texas Department of Insurance, the completion of its loss portfolio transfer from Houston International Insurance Group (HIIG).  This provides reinsurance protection and …

4 June, 2020

Loss Portfolio Transfer with Repwest Insurance Company

Randall & Quilter Investment Holdings Ltd. (‘R&Q’ or ‘the Group’) is pleased to announce that it has entered into a Loss Portfolio Transfer Reinsurance Contract and a Transfer Agreement with Repwest Insurance Company (“Repwest”). Repwest is based in Phoenix Arizona …

24 April, 2020

Acquisition of ICI Insurance Company Limited

Randall & Quilter Investment Holdings Ltd. (‘R&Q’ or ‘the Group’) is pleased to announce that its wholly owned subsidiary, Randall & Quilter II Holdings Limited, has signed an agreement with Imperial Chemical Industries Limited to acquire the entire issued share …

14 April, 2020

R&Q and UK P&I Club agree transfer of occupational diseases liabilities to R&Q

R&Q is pleased to announce that it has concluded an agreement with UK P&I Club, a leading provider of P&I insurance and other services to the international shipping community, to transfer the Club’s occupational disease liabilities, totalling $103.8 million on …

13 March, 2020